Tatva Chintan Pharma Chem Limited IPO – July 16 to 20

EspressoLogy

Tatva Chintan Pharma Chem Limited IPO – July 16 to 20

July 14, 2021
Tatva Chintan Pharma Chem Limited IPO – July 16 to 20

Tatva Chintan Pharma Chem Limited is coming out with a fresh public issue to raise Rs 500 crores from the market.

Key details of the issue:

  • Issue opens – July 16 (Friday)
  • Issue closes – July 20 (Tuesday)
  • Issue size – Rs 500 crores
  • Price band – Rs 1,073 to 1,083 per equity share
  • Bid lot – 13 shares and in multiples thereof

And here are some details of the company and further details on the Tatva Chintan Pharma Chem issue.

Company details:

Tatva Chintan Pharma Chem Limited is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC).

The company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally (Source: F&S Report). In addition, the company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe (Source: F&S Report).

The company serves customers across various industries, including the Automotive, Petroleum, Pharmaceutical, Agro Chemicals, Paints and Coatings, Dyes and Pigments, Personal Care and Flavour and Fragrances industries. Apart from its customers in India, it also exports its products to over 25 countries, including the USA, China, Germany, Japan, South Africa and the UK.

As on March 31, 2021, the company manufactured over 154 products, which can be divided into these 4 broad categories:

  • Structure Directing Agents
  • Phase Transfer Catalysts
  • Electrolyte salts for super capacitor batteries
  • Pharmaceutical and agrochemical intermediates and other specialty chemicals

The company's customers include Merck, Bayer AG, Asian Paints, Ipox Chemicals KFT, Laurus Labs, Tosoh Asia, SRF, Navin Fluorine International, Oriental Aromatics, Atul, Otsuka Chemical (I), Meghmani Organics, Divi’s Laboratories, Hawks Chemical Company, Firmenich Aromatics Prod. (I), Jiangsu Guotai Super Power New Materials and Jade Chem.

The company was incorporated on June 12, 1996, and currently operates through 2 manufacturing facilities situated at Ankleshwar and Dahej in Gujarat, both of which are strategically located very close to the Hazira port. It has a dedicated R&D facility that is recognized by the Department of Scientific and Industrial Research (DSIR), Government of India, at Vadodara, Gujarat, with state-of-the-art research and development infrastructure.

Issue size: Rs 500 crores

Issue break-up:

  • QIB – 50% of the offer – Rs 250 crores
  • NIB – 15% of the offer – Rs 75 crores
  • RET – 35% of the offer – Rs 175 crores

Listing: NSE and BSE

Registrar: Link Intime India Private Limited

UPI: All retail applications through brokers are compulsorily in UPI mode

Not an Espresso customer, but still want to apply for the Tatva Chintan Pharma Chem IPO? Become an Espresso customer in just 15 mins* by tapping here and take it from there! (* T&C apply)

Team Espresso
by Team Espresso

We care that you succeed

Bringing readers the latest happenings from the world of Trading and Investments specifically and Finance in general.